Fibro Daily

Label Debate At FDA Panel Opioid Hearing

Fibro Daily February 7, 2013

A citizen petition to change opioid labeling caused advocates and pain management groups to air concerns today during the first of only a 2 day Food and Drug Administration (FDA) hearing in Bethesda, MD.

Among the complaints, anesthesiologist Edward Michna, MD, said that insurance companies are using the petition to reduce access to care.

Read more:

Labeling Debated at FDA Panel Opioid Hearing

Comments

comments

Powered by Facebook Comments

Tagged with:

Comments are closed.

Login to your account

Can't remember your Password ?

Register for this site!